Loading
Stan Wang

Stan Wang

CEO & Founder, Thymmune
Stan Wang, MD, PhD, is CEO & Founder of Thymmune Therapeutics, a biotechnology company developing a machine learning-enabled thymic cell engineering platform to restore normal immune function in aging and disease. The company's cutting-edge approach in iPSC-thymic cell manufacturing can generate off-the-shelf cells at scale for a pipeline of therapies to treat immunodeficiencies, transplant related, and autoimmune disorders. Previously, he was Founding Chief Scientific Officer at Cellino Biotech. Dr. Wang received his PhD in stem cell biology & regenerative medicine from the University of Cambridge as a Gates Scholar and NIH-Cambridge Scholar, and his MD from Columbia University via the NIH Medical Scientist Training Program. He was a postdoctoral fellow with George Church at Harvard Medical School.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS